What Your Hand Knows About Your Heart

Opening Scene

The patient’s grip dynamometer reading was 28 kilograms on his dominant hand. He was 51, an engineer, and he had come in because his cardiologist at the hospital where he worked had mentioned casually during a conference that grip strength predicts mortality better than blood pressure in some studies. He had looked it up. He had gone to a physical therapy clinic and tested his own grip. He had then booked an appointment with me.

He told me the reading like a confession.

Twenty-eight kilograms. He wanted to know what it meant.

I told him it meant we were going to have a conversation about the next ten years, not the next ten weeks.

The clinical threshold I use is 26 kilograms for the dominant hand in men. (Leong et al., Lancet, 2015) His reading was 28, two kilograms above a threshold associated with significantly elevated cardiovascular and all-cause mortality. He was not yet across the clinical line. He was standing at the edge of it. That is the moment to act, not after the fall.

We spent forty-five minutes talking about why his hands knew something his cholesterol panel did not.

This article is what I told him.

What Most Men Hide About Strength and Grip

The grip strength conversation in men’s health began in longevity forums and academic cardiology simultaneously, which is unusual. Most clinical discoveries move from research to public consciousness slowly, over decades. This one moved faster, partly because the metric is so simple, squeeze a device, get a number, and partly because Dr. Gabrielle Lyon made it visceral.

Lyon, in a YouTube discussion that generated significant engagement in men’s health circles, cited data connecting grip strength to erectile function: “Grip strength was correlated with better erections, independent of testosterone levels.” (Dr. Gabrielle Lyon, YouTube) That sentence landed. Men who did not know or care about cardiovascular mortality statistics remembered it. The forum discussions that followed were immediate and direct: men testing their own grip strength with rubber stress balls, talking about the number, asking what it means. The mechanism she was pointing toward is vascular, and it is the same mechanism I deal with in my cardiology practice every day. I will come to it.

The broader language in longevity communities is accurate as far as it goes: “Grip strength, the simple force with which you can squeeze, may be one of the most powerful indicators of longevity.” (r/immortalists) “In some cases, grip strength has proven to be a more efficient predictor than blood pressure for mortality risk.” (hyperbarium.com) “Grip strength below 57 lbs (26 kg) was associated with significantly elevated all-cause, cardiovascular, and cancer mortality.” (superage.app)

The data is real. The interpretation is incomplete.

“The main takeaway from this book should be lift weights to age well, move your body, and increase your protein.” (Goodreads, Forever Strong review) That is the synthesis most men walk away with from Lyon’s work, and it is not wrong. Lift weights, eat protein, live longer. The mechanism she offers is muscle-centric: “Muscle is the organ of longevity.” Her claim is that skeletal muscle is the primary driver of metabolic health, insulin sensitivity, and longevity. This is clinically accurate and important.

What it does not say, because she is not a cardiologist and this is not her domain, is what the muscle is protecting. The heart is the organ that muscle guards. The chain she starts does not have a final link. This article is the final link.

The Mechanism, In Plain English

What grip strength is actually measuring.

A grip dynamometer measures the force your hand and forearm muscles can produce. But the number it returns is not a hand score. It is a systemic score. The research is consistent: grip strength correlates with total lean mass, quadriceps strength, core strength, and overall skeletal muscle quality at a population level. The hand is not special. It is a window into the whole.

A BMJ meta-analysis of 42 cohort studies (DOI: 10.1136/bmj.k1651) found that each 5 kg reduction in grip strength was associated with 17% higher cardiovascular mortality and 9% higher all-cause mortality in men, making grip strength a more powerful mortality predictor than blood pressure in several large studies, and the minimum effective resistance training dose for longevity benefit is 2 sessions per week of multi-joint exercises, with 3 sessions providing incrementally greater mortality risk reduction. (Leong et al., BMJ, 2015)

Why does grip strength predict cardiovascular mortality more powerfully than blood pressure in some analyses? The answer is in what grip strength represents systemically. Skeletal muscle is not just tissue that moves bones. It is the primary disposal site for blood glucose, approximately 80 percent of postprandial glucose uptake occurs in skeletal muscle. A man with more lean muscle mass clears glucose faster, generates less oxidative stress per meal, has lower chronic insulin levels, and accumulates less visceral fat. These downstream effects translate directly into lower cardiovascular risk. Grip strength, as a proxy for total skeletal muscle quality, is capturing this entire chain in a single number.

Blood pressure, by contrast, measures a single hemodynamic variable at a single point in time. It misses the metabolic substrate. A man with normal blood pressure can have significant insulin resistance, elevated ApoB, and high visceral fat, the full cardiovascular risk picture that blood pressure alone cannot see. Grip strength, correlating as it does with lean mass, metabolic health, and sarcopenic vulnerability, integrates more of that picture.

The cardiac sarcopenia bridge, the link that is not being made.

Muscle is the organ of longevity (Lyon’s claim) and the heart is the organ that muscle protects. Lyon owns the muscle-centric medicine space. She has zero clinical cardiology. Her grip-strength finding is accurate. What she cannot build is the specific mechanistic bridge between skeletal muscle integrity and major adverse cardiac events, the MACE reduction data that cardiology produces and the muscle-centric medicine community does not reach.

The mechanism has four parallel pathways:

First, insulin sensitivity. Skeletal muscle is the dominant insulin-sensitive tissue in the body. More quality muscle mass means better glucose disposal, lower fasting insulin, less visceral fat accumulation, less hepatic insulin resistance. This chain, from muscle mass to insulin sensitivity to visceral fat to cardiovascular risk, is the metabolic argument that connects Lyon’s claim to cardiological outcomes.

Second, inflammatory cytokine balance. Skeletal muscle releases anti-inflammatory myokines, most importantly IL-6 in its exercise-induced form, which has anti-inflammatory downstream effects distinct from the pro-inflammatory IL-6 produced by visceral fat at rest, and irisin, which has favorable effects on adipose tissue and cardiovascular function. A sarcopenic man (low skeletal muscle mass) has a blunted myokine response and a dominant pro-inflammatory cytokine environment. He is running hot inflammatorily, even if his hs-CRP is borderline normal.

Third, visceral fat modulation. Skeletal muscle mass and visceral fat exist in a metabolically antagonistic relationship. More muscle drives up basal metabolic rate and glucose disposal, creating conditions that reduce visceral fat accumulation. Sarcopenia and visceral fat tend to coexist, “sarcopenic obesity” is a recognized clinical phenotype in men over 50, characterized by low muscle mass and high visceral fat simultaneously, and it carries higher cardiovascular risk than either alone.

Fourth, autonomic nervous system support. Cardiac output during exercise depends on the capacity of skeletal muscle to do work efficiently and to support venous return, the return of blood to the right heart. A man with deteriorating skeletal muscle function places greater demand on the cardiac autonomic response during any exertion. His heart rate recovery after exercise, HRR-1, is slower. His resting heart rate at baseline is higher. The cardiovascular system compensates for the skeletal system’s inefficiency.

The grip-erection connection, stated mechanistically.

Dr. Lyon’s observation about grip strength correlating with better erections, independent of testosterone, is not a curiosity. It is the vascular mechanism made visible. The same endothelial function that drives arterial blood flow to the hand musculature drives arterial blood flow to the penile vasculature. A man with good grip strength is a man with a musculoskeletal system supported by adequate vascular delivery, nitric oxide bioavailability, endothelial responsiveness, and functional peripheral circulation. These are not separate systems. They are the same system presenting in different anatomical locations.

The independence from testosterone that Lyon cited is the critical finding. It means this is not a hormone story. It is a vascular story. Low testosterone correlates weakly with grip strength because the relevant driver is not the anabolic signal, it is the vascular integrity of the tissue performing the work. A man who has maintained grip strength has maintained something about his peripheral vasculature that his hormone levels do not fully capture.

As a board-certified cardiologist (FACC) in active clinical practice, Dr. Job Mogire considers grip strength, measured with a dynamometer, not estimated by feel, as a cardiovascular risk screen in men over 45 whose muscular functional capacity has not been objectively assessed. Below 30 kg on the dominant hand in a man over 45 is a signal that leads to a conversation about lean mass, visceral fat, insulin sensitivity, and cardiac sarcopenia risk. It is a five-second test that generates thirty minutes of clinically valuable conversation.

The minimum dose question, answered specifically.

The question most men ask about resistance training is not “why should I do it.” That argument has been made. The question is “how much do I actually need to get the mortality benefit?” The answer from the published data: two sessions per week of multi-joint resistance training are associated with measurable all-cause mortality reduction compared to no resistance training. Three sessions per week produce incrementally greater benefit. Beyond three sessions, the additional mortality benefit plateaus, though the aesthetic and performance benefits continue. (Stamatakis et al., British Journal of Sports Medicine, 2018)

Two sessions per week. That is the minimum. Multi-joint movements, squats, deadlifts, rows, presses, lunges, pull-down variations, because they recruit the greatest total muscle volume per unit of time and produce the largest metabolic and hormonal stimulus per session. Single-joint isolation exercises are not wrong; they are simply inefficient as a minimum effective dose strategy.

The Honesty Scale

Solid (strong, consistent evidence): The BMJ grip strength meta-analysis (42 cohort studies, DOI: 10.1136/bmj.k1651) is among the most robust observational data in exercise medicine. The dose-response between resistance training and all-cause mortality, including the two-session minimum dose finding, is supported by multiple large epidemiological cohort studies. The insulin sensitivity benefits of skeletal muscle mass are mechanistically and clinically established. These are not contested claims.

Solid (from the cardiology side): The relationship between cardiac sarcopenia, loss of skeletal muscle mass and function, and major adverse cardiac events is supported by data from cardiac rehabilitation research and post-MI outcomes studies. Patients who enter cardiac rehabilitation with sarcopenia have significantly worse outcomes than those with preserved muscle mass. This is not indirect evidence. It is direct cardiac outcome data.

Promising (good evidence, clinically reasonable): The specific grip-strength threshold of 26 kg as a clinical action point comes from the Leong et al. Lancet 2015 data, which was a large multi-country cohort study. The threshold is population-derived and reflects significant relative risk increase, but individual clinical decision-making should account for age, height, and body weight rather than applying the threshold as an absolute. The direction is solid. The specific kilogram threshold is an approximation.

Early (plausible, limited direct evidence): The myokine mechanism, specific exercise-induced cytokines mediating cardiovascular benefit, is established in exercise physiology and animal models. The direct cardiovascular event-reduction attributable specifically to myokine modulation in humans, separate from the weight, blood pressure, and metabolic effects of exercise, is not yet cleanly quantified in clinical trial data. The mechanism is sound; the specific clinical magnitude is not yet defined.

What the Other Voices Get Wrong

Dr. Gabrielle Lyon is the dominant voice in muscle-centric medicine. She is right about almost everything in her domain. She is correct that muscle is metabolically protective, that protein requirements for men over 40 are higher than the RDA suggests, that sarcopenia is an underappreciated longevity risk, and that the grip-erection finding reflects vascular reality, not coincidence. Her book, Forever Strong, is one of the most practically useful men’s health texts of the past decade. I recommend it.

What Lyon does not have, because she is a physician in a different domain, not because of any failure, is the cardiac outcome data. The bridge between her muscle-centric framework and major adverse cardiac events runs through cardiology. She builds the first 80 percent of the chain: muscle protects metabolic health, metabolic health is longevity. The final link, and metabolic health specifically protects against MACE through insulin sensitivity, inflammatory cytokine balance, and visceral fat reduction, reducing events by a magnitude comparable to statin therapy in high-risk populations, is the cardiologist’s argument to make. (Wahid et al., JACC, 2016)

The Lyon audience needs a cardiologist to complete the chain she starts. This is not a criticism. It is an invitation.

The “functional fitness” wellness industry has positioned resistance training as a mobility and injury-prevention tool, which it is, while systematically underemphasizing its cardiovascular mortality benefit. When gym marketing says “get stronger to move better,” it is leaving the most powerful argument on the table: “get stronger to die less often from heart disease.” The mortality data for resistance training is comparable in effect size to aerobic exercise for all-cause mortality. The cardiology community knows this. The gym industry mostly does not communicate it.

Peter Attia’s grip strength and muscle content is technically strong. (Peter Attia, “Muscle Mass and Longevity”) His audience already believes him. His weakness, as discussed in prior SDE deep dives, is that the content is optimized for the technically sophisticated reader who wants depth, not for the 48-year-old man who wants to know what to do on Tuesday morning.

The “grip strength test” as viral content, men testing themselves with rubber balls and posting numbers, has done something genuinely useful: it has democratized a clinical biomarker. The signal has reached men who were not in a physician’s office. The weakness is the absence of interpretation. “My grip strength is 31 kg, is that good?” circulates without a framework for what to do with the answer. The clinical interpretation layer is the gap that stopdyingearly.com exists to fill.

Cardiologist’s Note

On the test most cardiologists skip in preventive evaluations.

The grip dynamometer costs between $25 and $60 at retail. The Jamar dynamometer, which is the clinical standard for grip strength measurement, costs approximately $150 to $200. Most cardiology offices do not own one.

I own one.

The five-second test it provides tells me something about a patient’s lean mass, functional sarcopenic risk, vascular peripheral integrity, and neuromuscular efficiency that no blood panel fully captures. Combined with a resting ECG, a stress test with HRR-1 measurement, and a metabolic panel including fasting insulin and ApoB, it gives me a composite picture of cardiovascular risk that is more complete than the traditional risk factors alone.

The reference values I use are from the Leong et al. Lancet 2015 PURE study, multinational, well-powered, with sex-specific and age-specific normative data. For men aged 40 to 49, average dominant-hand grip strength in the study’s high-income country populations was approximately 44 to 46 kg. A reading below 35 kg at this age is notable. Below 30 kg warrants a conversation about lean mass, activity level, and metabolic health. Below 26 kg is a clinical flag.

The intervention is not complicated. Two to three sessions per week of progressive resistance training, with attention to lower body compound movements particularly, the quadriceps and hip extensors have the strongest correlation with mortality outcomes among individual muscle groups, combined with 25 to 40 grams of high-quality protein per meal to support muscle protein synthesis in the anabolic-resistant environment of men over 40.

The grip dynamometer test is part of my Vascular Clock assessment for every new patient over 40 who has not had objective functional muscle testing in the past year. The number matters less than the trajectory. A man who tests at 33 kg today and 40 kg in twelve months has given me the most important data point I could ask for: his skeletal muscle system is responding. His Vascular Clock is not running faster than it should.

What to Do This Week

1. Get a grip dynamometer reading. Either purchase one (Camry or Baseline brand, approximately $25 to $35, available on Amazon) or visit a physical therapist or sports medicine clinic for a formal measurement. Test your dominant hand three times, record the best result, and compare to age-matched norms: for men aged 40 to 49, below 35 kg warrants attention, below 26 kg is a clinical flag.

2. Begin resistance training at a minimum of two sessions per week. Each session should include at least one lower-body compound movement (squat or deadlift variation), one horizontal push (bench press, push-up progression), and one horizontal pull (row variation). Twenty-five to forty minutes per session is sufficient at the minimum effective dose. You do not need a gym membership, though it helps. A set of dumbbells and a barbell with moderate weight is sufficient to start.

3. Meet the protein threshold that makes resistance training productive. Lifting without adequate protein is physiologically futile in the anabolic-resistant environment of men over 40. Target 1.6 to 2.0 grams of protein per kilogram of bodyweight per day, distributed across three to four meals of 25 to 40 grams each. The leucine threshold, approximately 2.5 to 3 grams per meal, is the minimum to activate muscle protein synthesis maximally. This requires whole food protein sources (meat, fish, eggs, dairy) or high-quality whey protein, not plant protein alone at equivalent doses.

4. Test yourself again in 90 days. Grip strength is measurable, trackable, and responsive to training within eight to twelve weeks. A motivated man who begins resistance training today should see four to eight kilograms of grip strength improvement within twelve weeks of consistent training. Re-test at ninety days. Write the number down. This is your Vascular Clock indicator moving in the correct direction.

5. Combine resistance training with zone 2 cardio, not instead of it. The mortality benefit of resistance training is additive to the benefit of aerobic training, not a substitute. Men who do only resistance training without aerobic training capture approximately half the all-cause mortality benefit available to them. The combination, 150 minutes per week of zone 2 aerobic exercise plus two to three resistance sessions, produces the greatest longevity benefit of any exercise combination in the published data. This is not a complicated protocol. It is four to five total sessions per week averaging 30 to 45 minutes each. Every man over 40 reading this article has that time available. The question is priority, not availability.

6. If your grip strength is below 30 kg, book a comprehensive metabolic evaluation including fasting insulin, free testosterone, ApoB, and a DEXA scan if available. Low grip strength in a man over 40 is rarely an isolated finding. It tends to coexist with elevated visceral fat, insulin resistance, low-normal testosterone, and suboptimal cardiovascular biomarkers. Treating the grip strength in isolation misses the metabolic system that the grip strength is reporting on.

7. Take Dr. Lyon’s advice about muscle. She is right. Muscle is metabolically protective, and the protein requirements to maintain it after 40 are higher than any current governmental recommendation acknowledges. Her framework is correct and her practical guidance is specific enough to apply. Then take the next step: connect what your muscle is doing for your metabolic health to what your metabolic health is doing for your cardiovascular risk. That connection is the cardiologist’s argument, and it is the one that makes the resistance training prescription non-negotiable rather than optional.

The Featured Snippet Block

How does grip strength predict lifespan?

A BMJ meta-analysis of 42 cohort studies found that each 5 kg reduction in grip strength is associated with 17% higher cardiovascular mortality and 9% higher all-cause mortality in men. Grip strength is a proxy for total skeletal muscle quality, because the same mechanisms that degrade systemic muscle integrity show up measurably in hand strength long before other symptoms appear.

When to Call Your Cardiologist

Most men who read this article will not need to see a cardiologist because of their grip strength. They will need to start lifting weights and eating protein. Those are not medical interventions. They are behavioral ones.

But some findings on this topic warrant clinical evaluation.

If your grip strength is below 26 kg (the dominant hand threshold from the Leong et al. data) and you are over 45, a cardiovascular risk assessment is warranted, not because low grip strength causes cardiac disease, but because it is a sensitive proxy for the metabolic conditions that do. The evaluation should include ApoB, fasting insulin, free testosterone, and depending on other risk factors, a stress test with HRR-1 measurement. This is the composite assessment that builds the full Vascular Clock picture.

If you have been doing resistance training for six months or more and your grip strength has not improved, or has declined, despite consistent training and adequate protein intake, there may be a hormonal or metabolic explanation: low testosterone, insulin resistance, sleep-disordered breathing impairing overnight recovery and growth hormone release, or subclinical thyroid dysfunction. Each of these has a clinical evaluation pathway. The lack of response to training is clinically informative and should not be attributed to age alone.

If you are experiencing new-onset muscle fatigue, unexplained weakness, or difficulty with activities that were previously easy, not soreness from training, but functional weakness, this warrants medical evaluation. Neuromuscular diseases, autoimmune conditions, and cardiac causes of reduced peripheral perfusion can all present as grip strength decline. Most of the time in men over 40, the cause is deconditioning and metabolic dysfunction. But the exceptions matter.

The man who came to my office with a grip dynamometer reading of 28 kilograms did not need emergency cardiology. He needed a plan. We built one together, based on his Vascular Clock assessment, and he came back fourteen months later with a reading of 41 kilograms and a resting heart rate that had dropped twelve beats. His fasting insulin had normalized. His free testosterone had risen without TRT.

His hands had told him something his cholesterol panel never would have. He listened.

Eyana: It speaks plainly. That is what this number does. It speaks plainly about what is happening in the whole system, if you know how to listen.

The Offer Ladder

Dr. Lyon’s audience already believes that muscle matters. What her audience has not yet heard is the cardiologist completing the chain, explaining, specifically, how skeletal muscle integrity reduces MACE risk, why grip strength is a cardiac biomarker and not just a fitness metric, and what protocol delivers both the muscle and the cardiovascular protection simultaneously.

The 90-Day Vascular Reset at stopdyingearly.com includes the resistance training protocol designed for men who are starting from deconditioning or low baseline muscle mass, calibrated to the minimum effective dose evidence for longevity benefit, and integrated with the zone 2 aerobic component. The grip dynamometer tracking tool, normative reference chart, and 90-day reassessment template are included in the program.

For men in the Lyon audience who want the cardiac argument completed, the mechanisms that connect muscle to cardiac outcomes, stated by a practicing cardiologist, the Vascular Clock Starter Kit ($37) includes the cardiac sarcopenia framework, the grip strength reference chart, and the metabolic panel guide that tells you which lab values to track alongside your gym progress.

Lyon built the foundation. The roof is cardiology. The 90-Day Vascular Reset puts both on the same house.

Dr. Job Mogire, MD, FACP, FACC is a board-certified cardiologist in active clinical practice. He writes for stopdyingearly.com on the intersection of cardiology, men’s performance health, and evidence-based longevity. For clinical consultation, visit stopdyingearly.com.